List of Tables
Table 1. Global Market Hepatic Encephalopathy Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Hepatic Encephalopathy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Hepatic Encephalopathy Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Hepatic Encephalopathy Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Hepatic Encephalopathy Therapeutics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Hepatic Encephalopathy Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Hepatic Encephalopathy Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Hepatic Encephalopathy Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Hepatic Encephalopathy Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Hepatic Encephalopathy Therapeutics Revenue Market Share by Type (2024-2029)
Table 11. North America Hepatic Encephalopathy Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Hepatic Encephalopathy Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Hepatic Encephalopathy Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Hepatic Encephalopathy Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Hepatic Encephalopathy Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Hepatic Encephalopathy Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Hepatic Encephalopathy Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Hepatic Encephalopathy Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Hepatic Encephalopathy Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Hepatic Encephalopathy Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Hepatic Encephalopathy Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Hepatic Encephalopathy Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global Hepatic Encephalopathy Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2024-2029)
Table 26. North America Hepatic Encephalopathy Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Hepatic Encephalopathy Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Hepatic Encephalopathy Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Hepatic Encephalopathy Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Hepatic Encephalopathy Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Hepatic Encephalopathy Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Hepatic Encephalopathy Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Hepatic Encephalopathy Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Hepatic Encephalopathy Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Hepatic Encephalopathy Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Hepatic Encephalopathy Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Hepatic Encephalopathy Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatic Encephalopathy Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Hepatic Encephalopathy Therapeutics Market
Table 40. Global Hepatic Encephalopathy Therapeutics Key Players Headquarters and Area Served
Table 41. Hepatic Encephalopathy Therapeutics Product Solution and Service
Table 42. Global Hepatic Encephalopathy Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. ASKA Pharmaceutical Basic Information List
Table 45. ASKA Pharmaceutical Description and Business Overview
Table 46. ASKA Pharmaceutical Hepatic Encephalopathy Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Hepatic Encephalopathy Therapeutics Business of ASKA Pharmaceutical (2018-2023)
Table 48. ASKA Pharmaceutical Recent Developments
Table 49. COSMO Pharmaceuticals Basic Information List
Table 50. COSMO Pharmaceuticals Description and Business Overview
Table 51. COSMO Pharmaceuticals Hepatic Encephalopathy Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Hepatic Encephalopathy Therapeutics Business of COSMO Pharmaceuticals (2018-2023)
Table 53. COSMO Pharmaceuticals Recent Developments
Table 54. Fresenius Kabi Basic Information List
Table 55. Fresenius Kabi Description and Business Overview
Table 56. Fresenius Kabi Hepatic Encephalopathy Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Hepatic Encephalopathy Therapeutics Business of Fresenius Kabi (2018-2023)
Table 58. Fresenius Kabi Recent Developments
Table 59. Mallinckrodt Pharmaceuticals Basic Information List
Table 60. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 61. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Hepatic Encephalopathy Therapeutics Business of Mallinckrodt Pharmaceuticals (2018-2023)
Table 63. Mallinckrodt Pharmaceuticals Recent Developments
Table 64. Lupin Basic Information List
Table 65. Lupin Description and Business Overview
Table 66. Lupin Hepatic Encephalopathy Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Hepatic Encephalopathy Therapeutics Business of Lupin (2018-2023)
Table 68. Lupin Recent Developments
Table 69. Salix Pharmaceuticals Basic Information List
Table 70. Salix Pharmaceuticals Description and Business Overview
Table 71. Salix Pharmaceuticals Hepatic Encephalopathy Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Hepatic Encephalopathy Therapeutics Business of Salix Pharmaceuticals (2018-2023)
Table 73. Salix Pharmaceuticals Recent Developments
Table 74. Teva Pharmaceutical Basic Information List
Table 75. Teva Pharmaceutical Description and Business Overview
Table 76. Teva Pharmaceutical Hepatic Encephalopathy Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Hepatic Encephalopathy Therapeutics Business of Teva Pharmaceutical (2018-2023)
Table 78. Teva Pharmaceutical Recent Developments
Table 79. Bausch Health Basic Information List
Table 80. Bausch Health Description and Business Overview
Table 81. Bausch Health Hepatic Encephalopathy Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Hepatic Encephalopathy Therapeutics Business of Bausch Health (2018-2023)
Table 83. Bausch Health Recent Developments
Table 84. North America Hepatic Encephalopathy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 85. North America Hepatic Encephalopathy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 86. Europe Hepatic Encephalopathy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 87. Europe Hepatic Encephalopathy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 88. Asia-Pacific Hepatic Encephalopathy Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 89. Asia-Pacific Hepatic Encephalopathy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific Hepatic Encephalopathy Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Hepatic Encephalopathy Therapeutics Market Share by Region (2018-2023)
Table 92. Asia-Pacific Hepatic Encephalopathy Therapeutics Market Share by Region (2024-2029)
Table 93. Latin America Hepatic Encephalopathy Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 94. Latin America Hepatic Encephalopathy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 95. Latin America Hepatic Encephalopathy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 96. Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 97. Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 98. Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 99. Hepatic Encephalopathy Therapeutics Market Trends
Table 100. Hepatic Encephalopathy Therapeutics Market Drivers
Table 101. Hepatic Encephalopathy Therapeutics Market Challenges
Table 102. Hepatic Encephalopathy Therapeutics Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatic Encephalopathy Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Hepatic Encephalopathy Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Hepatic Encephalopathy Therapeutics Market Share by Regions: 2022 VS 2029
Figure 4. Global Hepatic Encephalopathy Therapeutics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Hepatic Encephalopathy Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Hepatic Encephalopathy Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Hepatic Encephalopathy Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Hepatic Encephalopathy Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Hepatic Encephalopathy Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Kits
Figure 11. Global Kits Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Reagents
Figure 13. Global Reagents Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Instruments
Figure 15. Global Instruments Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global Hepatic Encephalopathy Therapeutics Market Size Share by Type: 2022 & 2029
Figure 17. North America Hepatic Encephalopathy Therapeutics Revenue Market Share by Type (2018-2029)
Figure 18. Europe Hepatic Encephalopathy Therapeutics Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific Hepatic Encephalopathy Therapeutics Revenue Market Share by Type (2018-2029)
Figure 20. Latin America Hepatic Encephalopathy Therapeutics Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa Hepatic Encephalopathy Therapeutics Revenue Market Share by Type (2018-2029)
Figure 22. Acute Liver Failure Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Portal Systemic Bypass without Liver Disease Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Liver Cirrhosis Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Global Hepatic Encephalopathy Therapeutics Market Size Share by Application: 2022 & 2029
Figure 26. North America Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2018-2029)
Figure 27. Europe Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2018-2029)
Figure 28. Asia-Pacific Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2018-2029)
Figure 29. Latin America Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2018-2029)
Figure 30. Middle East and Africa Hepatic Encephalopathy Therapeutics Revenue Market Share by Application (2018-2029)
Figure 31. Hepatic Encephalopathy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Hepatic Encephalopathy Therapeutics Market Share in 2022
Figure 33. North America Hepatic Encephalopathy Therapeutics Market Share by Country (2018-2029)
Figure 34. U.S. Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 35. Canada Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 36. Germany Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 37. France Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 38. U.K. Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 39. Italy Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 40. Russia Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 41. Nordic Countries Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 42. Asia-Pacific Hepatic Encephalopathy Therapeutics Market Share by Region (2018-2029)
Figure 43. China Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 44. Japan Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 45. South Korea Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 47. India Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 48. Australia Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 49. Latin America Hepatic Encephalopathy Therapeutics Market Share by Country (2018-2029)
Figure 50. Mexico Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 51. Brazil Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Hepatic Encephalopathy Therapeutics Market Share by Country (2018-2029)
Figure 53. Turkey Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 55. UAE Hepatic Encephalopathy Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report